To view the entire topic, please log in or purchase a subscription.
Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:
-- The first section of this topic is shown below --
Synonym/Acronym:
Transthyretin.
Rationale
To assess nutritional status and evaluate liver function toward diagnosing disorders such as malnutrition and chronic kidney disease.
Patient Preparation
There are no fluid, activity, or medication restrictions unless by medical direction. The patient may be instructed to fast prior to the test; protocols vary among facilities.
Normal Findings
Method: Nephelometry.
Age | Conventional Units | SI Units (Conventional Units × 10) |
---|---|---|
Newborn–1 mo | 7–39 mg/dL | 70–390 mg/L |
1–6 mo | 8–34 mg/dL | 80–340 mg/L |
6 mo–4 yr | 11–23 mg/dL | 110–230 mg/L |
5–15 yr | 14–35 mg/dL | 140–350 mg/L |
16–17 yr | 20–43 mg/dL | 20–43 mg/L |
Adult/older adult | 20–42 mg/dL | 200–420 mg/L |
Critical Findings and Potential Interventions
N/A
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Synonym/Acronym:
Transthyretin.
Rationale
To assess nutritional status and evaluate liver function toward diagnosing disorders such as malnutrition and chronic kidney disease.
Patient Preparation
There are no fluid, activity, or medication restrictions unless by medical direction. The patient may be instructed to fast prior to the test; protocols vary among facilities.
Normal Findings
Method: Nephelometry.
Age | Conventional Units | SI Units (Conventional Units × 10) |
---|---|---|
Newborn–1 mo | 7–39 mg/dL | 70–390 mg/L |
1–6 mo | 8–34 mg/dL | 80–340 mg/L |
6 mo–4 yr | 11–23 mg/dL | 110–230 mg/L |
5–15 yr | 14–35 mg/dL | 140–350 mg/L |
16–17 yr | 20–43 mg/dL | 20–43 mg/L |
Adult/older adult | 20–42 mg/dL | 200–420 mg/L |
Critical Findings and Potential Interventions
N/A
There's more to see -- the rest of this entry is available only to subscribers.